Fulong Wang
State Key Laboratory Of Oncology In South China
Guangzhou, China
Guangzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
Serum biomarkers REG1A and REG3A combined with the traditional CEA represent a novel nomogram for the screening and risk stratification of colorectal cancer.
Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico
Published: May 04, 2024
Dissected subgroups predict the risk of recurrence of stage II colorectal cancer and select rational treatment.
Journal: Frontiers in immunology
Published: November 22, 2022
Postoperative circulating tumor DNA as markers of recurrence risk in stages II to III colorectal cancer.
Journal: Journal of hematology & oncology
Published: March 30, 2021
Identification of Two Subgroups of FOLFOX Resistance Patterns and Prediction of FOLFOX Response in Colorectal Cancer Patients.
Journal: Cancer investigation
Published: December 01, 2020
Prolonged surveillance of colorectal cancer patients after curative surgeries beyond five years of follow-up.
Journal: Annals of translational medicine
Published: February 13, 2020
An early report of a screening program for colorectal cancer in Guangzhou, China.
Journal: Annals of translational medicine
Published: February 13, 2020
Right- and left-sided stage III colon cancers present different prognostic outcomes of oxaliplatin-based adjuvant chemotherapy after curative resection.
Journal: Cancer management and research
Published: August 25, 2018
Total mesorectal excision with or without preoperative chemoradiotherapy for resectable mid/low rectal cancer: a long-term analysis of a prospective, single-center, randomized trial.
Journal: Cancer communications (London, England)
Published: February 14, 2018
Last Updated: 09/26/2026